Hasni, Sarfaraz A. http://orcid.org/0000-0002-4164-8837
Gupta, Sarthak http://orcid.org/0000-0001-8255-3554
Davis, Michael
Poncio, Elaine
Temesgen-Oyelakin, Yenealem
Carlucci, Philip M. http://orcid.org/0000-0002-9729-4572
Wang, Xinghao http://orcid.org/0000-0001-8264-8537
Naqi, Mohammad
Playford, Martin P.
Goel, Rishi R. http://orcid.org/0000-0003-1715-5191
Li, Xiaobai
Biehl, Ann J.
Ochoa-Navas, Isabel
Manna, Zerai
Shi, Yinghui
Thomas, Donald http://orcid.org/0000-0002-3976-3131
Chen, Jinguo
Biancotto, Angélique
Apps, Richard
Cheung, Foo
Kotliarov, Yuri http://orcid.org/0000-0002-6558-8883
Babyak, Ashley L. http://orcid.org/0000-0002-2399-5122
Zhou, Huizhi
Shi, Rongye
Stagliano, Katie
Tsai, Wanxia Li
Vian, Laura
Gazaniga, Nathalia
Giudice, Valentina http://orcid.org/0000-0002-7492-6848
Lu, Shajia
Brooks, Stephen R.
MacKay, Meggan
Gregersen, Peter
Mehta, Nehal N.
Remaley, Alan T.
Diamond, Betty http://orcid.org/0000-0002-3250-3804
O’Shea, John J.
Gadina, Massimo
Kaplan, Mariana J. http://orcid.org/0000-0003-2968-0815
Article History
Received: 3 April 2020
Accepted: 22 April 2021
First Online: 7 June 2021
Change Date: 24 June 2021
Change Type: Update
Change Details: In the original version of this Article, the given and family names of author John J. O'Shea were incorrectly tagged, leading to incorrect indexing. This error has now been corrected. The PDF and HTML versions displayed the name correctly at the time of publication.
Competing interests
: The NIH and J.J.O.S. have a patent related to JAK inhibitors and receive royalties. The NIH and J.J.O.S. have had a collaborative agreement and development award (CRADA) with Pfizer that pertains to JAK inhibition and tofacitinib. The NIH and J.J.O.S. have an ongoing CRADA for new JAK inhibitors. The remaining authors declare no competing interests.